450 related articles for article (PubMed ID: 31684781)
1. Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution.
Salas MQ; Mercadal S; Domingo Domenech E; Oliveira AC; Encuentra M; Climent F; Andrade Campos M; Aguilera C; Fernández de Sevilla A; Sureda A; González-Barca E
Leuk Lymphoma; 2020 Mar; 61(3):575-581. PubMed ID: 31684781
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Zhong Q; Chen H; Chen D; Qin Y; He X; Yang Y; Yang J; Liu P; Zhou S; Yang S; Zhou Y; Tang L; Chen C; Shi Y
Ann Hematol; 2024 Jan; 103(1):211-226. PubMed ID: 37861735
[TBL] [Abstract][Full Text] [Related]
3. Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models.
Jelicic J; Juul-Jensen K; Bukumiric Z; Roost Clausen M; Ludvigsen Al-Mashhadi A; Pedersen RS; Poulsen CB; Brown P; El-Galaly TC; Stauffer Larsen T
Blood Cancer J; 2023 Oct; 13(1):157. PubMed ID: 37833260
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and prognostic features of 63 HIV-associated diffuse large B-cell lymphoma: a single-center real-world study in China].
Wang CY; Liu J; Liang XP; Guo BL; Hu RZ; Liu Y
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):203-208. PubMed ID: 35405777
[No Abstract] [Full Text] [Related]
5. Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.
Gutierrez A; Bento L; Diaz-Lopez A; Barranco G; Garcia-Recio M; Lopez-Guillermo A; Dlouhy I; Rovira J; Rodriguez M; Sanchez Pina JM; Baile M; Martín A; Novelli S; Sancho JM; García O; Salar A; Bastos-Oreiro M; Rodriguez-Salazar MJ; Fernandez R; de la Cruz F; Queizan JA; González de Villambrosia S; Cordoba R; López A; Luzardo H; García D; Sastre-Serra J; Garcia JF; Montalban C; Cabanillas F; Rodríguez J
Eur J Haematol; 2020 May; 104(5):400-408. PubMed ID: 31804029
[TBL] [Abstract][Full Text] [Related]
6. Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Ghesquières H; Cherblanc F; Belot A; Micon S; Bouabdallah KK; Esnault C; Fornecker LM; Thokagevistk K; Bonjour M; Bijou F; Haioun C; Morineau N; Ysebaert L; Damaj G; Tessoulin B; Guidez S; Morschhauser F; Thiéblemont C; Chauchet A; Gressin R; Jardin F; Fruchart C; Labouré G; Fouillet L; Lionne-Huyghe P; Bonnet A; Lebras L; Amorim S; Leyronnas C; Olivier G; Guieze R; Houot R; Launay V; Drénou B; Fitoussi O; Detourmignies L; Abraham J; Soussain C; Lachenal F; Pica GM; Fogarty P; Cony-Makhoul P; Bernier A; Le Guyader-Peyrou S; Monnereau A; Boissard F; Rossi C; Camus V
Blood Adv; 2024 Jan; 8(2):296-308. PubMed ID: 37874913
[TBL] [Abstract][Full Text] [Related]
7. Adding MYC/BCL2 double expression to NCCN-IPI may not improve prognostic value to an acceptable level.
Warnnissorn N; Kanitsap N; Niparuck P; Boonsakan P; Kulalert P; Limvorapitak W; Bhoopat L; Saengboon S; Suriyonplengsaeng C; Chantrathammachart P; Puavilai T; Chuncharunee S
Blood Res; 2024 Feb; 59(1):2. PubMed ID: 38485822
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence.
de Pádua Covas Lage LA; De Vita RN; de Oliveira Alves LB; Jacomassi MD; Culler HF; Reichert CO; de Freitas FA; Rocha V; Siqueira SAC; de Oliveira Costa R; Pereira J
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672542
[TBL] [Abstract][Full Text] [Related]
9. SurvIAE: Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression data.
Zaccaria GM; Altini N; Mezzolla G; Vegliante MC; Stranieri M; Pappagallo SA; Ciavarella S; Guarini A; Bevilacqua V
Comput Methods Programs Biomed; 2024 Feb; 244():107966. PubMed ID: 38091844
[TBL] [Abstract][Full Text] [Related]
10. A nomogram prognostic model for diffuse large B-cell lymphoma based on SUVmax and GNRI in elderly patients.
Li M; Lu H; Fan J; Dai M; Su C
EJHaem; 2023 Nov; 4(4):1030-1041. PubMed ID: 38024603
[TBL] [Abstract][Full Text] [Related]
11. Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study.
Ikeda D; Oura M; Uehara A; Tabata R; Narita K; Takeuchi M; Machida Y; Matsue K
Blood Adv; 2024 Apr; 8(8):1893-1897. PubMed ID: 38359408
[No Abstract] [Full Text] [Related]
12. New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group.
Bastos-Oreiro M; Abrisqueta P; Gutierrez A; Jiménez Ubieto A; Poza M; Fernanez-Caldas P; LLacer MJ; Gonzalez de Villambrosia S; Córdoba R; López A; Ceballos E; Navarro B; Muntañola A; Donato E; Diez-Baeza E; Escoda L; Luzardo H; Peñarrubia MJ; García Belmonte D; Pardal E; Lozada C; Martín García-Sancho A
Hemasphere; 2024 Apr; 8(4):e70. PubMed ID: 38650598
[No Abstract] [Full Text] [Related]
13. Visible and near-infrared hyperspectral imaging techniques allow the reliable quantification of prognostic markers in lymphomas: A pilot study using the Ki67 proliferation index as an example.
Willenbacher E; Brunner A; Willenbacher W; Zelger B; Wolf D; Rogge D; Tappert M; Pallua JD
Exp Hematol; 2020 Nov; 91():55-64. PubMed ID: 32966868
[TBL] [Abstract][Full Text] [Related]
14. MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era.
Nishimura N; Takeuchi K; Asaka R; Tuyama N; Inoue N; Kusano Y; Mishima Y; Yokoyama M; Terui Y
Leuk Res; 2020 Oct; 97():106426. PubMed ID: 32781214
[TBL] [Abstract][Full Text] [Related]
15. New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO).
Bento L; Díaz-López A; Barranco G; Martín-Moreno AM; Baile M; Martín A; Sancho JM; García O; Rodríguez M; Sánchez-Pina JM; Novelli S; Salar A; Bastos M; Rodríguez-Salazar MJ; González de Villambrosia S; Córdoba R; García-Recio M; Martínez-Serra J; Del Campo R; Luzardo H; García D; Hong A; Abrisqueta P; Sastre-Serra J; Roca P; Rodríguez J; Gutiérrez A;
Br J Haematol; 2020 Mar; 188(6):888-897. PubMed ID: 31782146
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features and prognostic significance of CD30 expression in
Salas MQ; Climent F; Tapia G; DomingoDomènech E; Mercadal S; Oliveira AC; Aguilera C; Olga G; Moreno Velázquez M; Andrade-Campos M; Encuentra M; Fernández de Sevilla A; Sureda A; Sancho JM; González-Barca E
Biomarkers; 2020 Feb; 25(1):69-75. PubMed ID: 31752540
[No Abstract] [Full Text] [Related]
17. Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
Zhou H; Xu-Monette ZY; Xiao L; Strati P; Hagemeister FB; He Y; Chen H; Li Y; Manyam GC; Li Y; Montes-Moreno S; Piris MA; Young KH
Blood Cancer J; 2020 May; 10(5):49. PubMed ID: 32366834
[TBL] [Abstract][Full Text] [Related]
18. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI.
Ruppert AS; Dixon JG; Salles G; Wall A; Cunningham D; Poeschel V; Haioun C; Tilly H; Ghesquieres H; Ziepert M; Flament J; Flowers C; Shi Q; Schmitz N
Blood; 2020 Jun; 135(23):2041-2048. PubMed ID: 32232482
[TBL] [Abstract][Full Text] [Related]
19. Lenalidomide in DLBCL: are we past the cell of origin?
Goldfinger M; Cooper DL
Clin Adv Hematol Oncol; 2021 May; 19(5):320-325. PubMed ID: 33989279
[TBL] [Abstract][Full Text] [Related]
20. Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma.
Goyal RK; Jain P; Nagar SP; Le H; Kabadi SM; Davis K; Kaye JA; Du XL; Wang M
Leuk Lymphoma; 2021 Jun; 62(6):1325-1334. PubMed ID: 33966583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
